Literature DB >> 15044932

Severe congenital chylothorax treated with octreotide.

Sandra Young1, Stacey Dalgleish, Andrew Eccleston, Albert Akierman, Doug McMillan.   

Abstract

We report a neonate with severe congenital chylothorax. Subcutaneous octreotide was added to the standard treatment regime. The chylothorax resolved with no observed side effects.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15044932     DOI： 10.1038/sj.jp.7211053

Source DB:  PubMed          Journal:  J Perinatol        ISSN： 0743-8346            Impact factor:   2.521


  6 in total

1.  Congenital chylothorax--successful management with chemical pleurodesis.

Authors:  Srinivas Murki; Md Faheemuddin; Pramod Gaddam
Journal:  Indian J Pediatr       Date:  2010-02-08       Impact factor: 1.967

2.  Congenital Chylothorax of the Newborn: A Systematic Analysis of Published Cases between 1990 and 2018.

Authors:  Bernhard Resch; Gülsen Sever Yildiz; Friedrich Reiterer
Journal:  Respiration       Date:  2021-09-01       Impact factor: 3.580

Review 3.  Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.

Authors:  Charles C Roehr; Andreas Jung; Hans Proquitté; Oliver Blankenstein; Hannes Hammer; Kokila Lakhoo; Roland R Wauer
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440

4.  [Role of lymphatic scintigraphy and surgery in congenital chylothorax].

Authors:  Jihène Methlouthi; Nabiha Mahdhaoui; Manel Bellalah; Nouir Selsabil; Ayache Hedia; Raja Sfar; Habib Essabah; Nouri Abdellatif; Nouri Sonia; Seboui Hassen
Journal:  Pan Afr Med J       Date:  2016-08-22

5.  Octreotide Use in Neonates: A Case Series.

Authors:  Syed Ahmed Zaki; Mohan B Krishnamurthy; Atul Malhotra
Journal:  Drugs R D       Date:  2018-09

6.  Low Dose of Octreotide Can be Helpful in the Management of Congenital Chylothorax.

Authors:  Shahla Afsharpaiman; Mohammad Saeid Rezaee Zavareh; Mohammad Torkaman
Journal:  Iran Red Crescent Med J       Date:  2015-10-13       Impact factor: 0.611
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.